The FDA still believes the covid virus is so deadly that it has to mandate the untested and adversely reacted vaccine on babies. After only 24 patients were tested, the FDA approved the Pfizer vaccine, which has been proven to Not prevent the disease as numerous individuals took the shot and later did contract the disease.
Bivalent, the Pfizer-BioNTech vaccine targeted at children six months to 4 years, will be allowed a single booster injection two months after receiving the initial dose, the FDA announced on March 14. Peter Marks, the FDA’s Center for Biologics Evaluation and Research director said,
Currently available data show that vaccination remains the best defense against severe disease, hospitalization and death caused by COVID-19 across all age groups [1].
COVID shots, developed and released in a fraction of the time vaccines typically take, continue to raise safety concerns among Americans. The federal Vaccine Adverse Events Reporting system (VAERS) reports 34,653 deaths, 193,913 hospitalizations, 18,766 heart attacks, and 26,584 myocarditis and pericarditis cases as of March 3 [2].
Vaccination against COVID for the young has the most controversy, as data shows the virus poses little risk to children. FDA’s latest decision reiterates previous allegations that it is not doing due diligence in approving shots for children.
Notes:
- ^@article{LifeSite2023Mar, author = {{LifeSite}}, title = {{FDA approves COVID boosters for 6-month-olds, citing trial with just 24 patients – LifeSite}}, journal = {LifeSite}, year = {2023}, month = mar, url = {https://www.lifesitenews.com/news/fda-approves-covid-boosters-for-6-month-olds-citing-trial-with-just-24-patients/?utm_source=featured-news&utm_campaign=usa} } (go back ↩)
- ^@article{LifeSite2023Mar, author = {{LifeSite}}, title = {{FDA approves COVID boosters for 6-month-olds, citing trial with just 24 patients – LifeSite}}, journal = {LifeSite}, year = {2023}, month = mar, url = {https://www.lifesitenews.com/news/fda-approves-covid-boosters-for-6-month-olds-citing-trial-with-just-24-patients/?utm_source=featured-news&utm_campaign=usa} } (go back ↩)